Folate, vitamin B12 and birth defects

Area of Science:

• Obstetrics and Gynecology
• Genetics
• Public Health

Background:

• Folic acid/folate is proven to prevent most neural tube defects (NTDs) when taken periconceptionally.
• The protective effect of folic acid/folate on oral-facial clefts (OFCs) remains unclear, with inconsistent study findings.
• Conflicting evidence exists regarding the MTHFR C677T variant's association with OFC risk, unlike its established link to NTDs.

Purpose of the Study:

• To evaluate the current evidence on folic acid/folate's role in preventing oral-facial clefts (OFCs).
• To investigate the association between the MTHFR C677T variant and OFC risk.
• To clarify the discrepancies in existing research regarding folate supplementation and OFCs.

Main Methods:

• Systematic review of epidemiological studies and meta-analyses.
• Analysis of genetic association studies focusing on MTHFR polymorphisms.
• Comparative analysis of evidence for NTD prevention versus OFC prevention.

Main Results:

• Evidence for folic acid/folate preventing OFCs is inconclusive, with some studies showing a benefit and others showing none.
• Reports on whether the MTHFR C677T variant increases OFC risk are contradictory.
• In contrast to NTDs, a clear preventive role for folic acid/folate and a definitive risk association for MTHFR C677T in OFCs are not established.

Conclusions:

• The role of periconceptional folic acid/folate in preventing oral-facial clefts requires further investigation.
• The contribution of the MTHFR C677T variant to OFC etiology is not clearly defined.
• More research is needed to resolve conflicting findings and establish definitive guidelines for OFC prevention.